Hemab Therapeutics Holdings, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Hemab Therapeutics Holdings, Inc. (COAG) had Convertible Preferred Stock, Shares Issued upon Conversion of 26.50 million shares as of 2026-03-31, per its 10-Q filed 2026-05-21.
Financial Statements › Notes › Stockholders' Equity Note › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2026-08-11
- 2026-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 26.50M shares.
- 2025-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 26.50M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2026-03-31 | 26.50M shares 10-Q · filed 2026-05-21 |
| 2025-12-31 | 26.50M shares 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |